InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Pontus Forsell. Director active across 1 company, notably AlzeCure Pharma AB. Cumulatively, 1 disclosures have been published. History available since 19 January 2021. The latest transaction was filed on 19 January 2021 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
1 of 1 declaration